Join Growin Stock Community!

Inspira technologies oxy b.h.n. ltd.IINNW.US Overview

US StockHealthcare
(No presentation for IINNW)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

IINNW AI Insights

IINNW Overall Performance

IINNW AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

IINNW Recent Performance

3.76%

Inspira technologies oxy b.h.n. ltd.

0.05%

Avg of Sector

-0.31%

S&P500

IINNW PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

IINNW Key Information

IINNW Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

IINNW Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.

Price of IINNW

IINNW FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

IINNW Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.50
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
1113.59
METRIC
VALUE
vs. INDUSTRY
Gross Margin
100.00%
Net Margin
64.30%
Revenue Growth (YoY)
0.00%
Profit Growth (YoY)
0.00%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.50
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
1113.59
Gross Margin
100.00%
Net Margin
64.30%
Revenue Growth (YoY)
0.00%
Profit Growth (YoY)
0.00%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%

  • When is IINNW's latest earnings report released?

    The most recent financial report for Inspira technologies oxy b.h.n. ltd. (IINNW) covers the period of 2023Q4 and was published on 2023/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating IINNW's short-term business performance and financial health. For the latest updates on IINNW's earnings releases, visit this page regularly.

  • How much cash does IINNW have?

    At the end of the period, Inspira technologies oxy b.h.n. ltd. (IINNW) held Total Cash and Cash Equivalents of 5.11M, accounting for 0.63 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Is IINNW's EPS continuing to grow?

    According to the past four quarterly reports, Inspira technologies oxy b.h.n. ltd. (IINNW)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.19. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.